基本信息
浏览量:10
职业迁徙
个人简介
In those positions, Dr. Taub oversaw clinical development and drug discovery programs in cardiovascular and metabolic diseases including the conduct of a series of Phase I and II proof of concept clinical trials. Dr. Taub led drug discovery, including target identification, lead optimization and advancement of preclinical candidates into clinical development. From 2000 through 2003, Dr. Taub worked at Bristol-Myers Squibb Co. and DuPont Pharmaceutical Company in a variety of positions, including Executive Director of CNS and metabolic diseases research. Before becoming a pharmaceutical executive, Dr. Taub was a tenured Professor of Genetics and Medicine at the University of Pennsylvania. Dr. Taub is the author of more than 120 research articles.
研究兴趣
论文共 109 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rohit Loomba,Jorn Schattenberg,Rebecca Taub, Dominic Labriola,Mazen Noureddin,Vlad Ratziu, Stephen A. Harrison
Gastroenterologyno. 5 (2024): S-1550
ALIMENTARY PHARMACOLOGY & THERAPEUTICSno. 1 (2024): 51-63
NEW ENGLAND JOURNAL OF MEDICINEno. 6 (2024): 497-509
The New England journal of medicineno. 17 (2024): 1632-1633
Stephen Harrison,Rebecca Taub,Guy Neff,Mustafa Bashir, Dominic Labriola,Sam Moussa, Naim Alkhouri,Kathryn Jean Lucas
JOURNAL OF HEPATOLOGY (2023): S815-S816
HEPATOLOGY (2023): S887-S887
引用0浏览0引用
0
0
HEPATOLOGY (2023): S766-S767
引用0浏览0引用
0
0
Nature Medicineno. 11 (2023): 2919-2928
Naim Alkhouri,Pierre Bedossa,Cynthia D. Guy,Joern M. Schattenberg,Rohit Loomba,Rebecca A. Taub, Dominic Labriola,Sam Moussa, Guy W. Neff,Arun Sanyal,Mazen Noureddin, Meena B. Bansal,
HEPATOLOGY (2023): S1207-S1213
引用0浏览0引用
0
0
Pratik Mistry, Adam Stanford-Moore,Robert Egger,Jonathan Glickman, Brian Baker, Nidhi Chandra,Dinkar Juyal,Archit Khosla,Michael Drage,Murray Resnick,Katy Wack, Jim Hennan,
JOURNAL OF HEPATOLOGY (2023): S790-S790
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn